The MYC family of cellular oncogenes includes c-Myc, N-myc, and L-myc, which encode transcriptional regulators involved in the control of cell proliferation and death. Accordingly, these genes become aberrantly activated and expressed in specific types of cancers. For example, c-Myc translocations occur frequently in human B lymphoid tumors, while N-myc gene amplification is frequent in human neuroblastomas. The observed association between aberrations in particular MYC family genes and specific subsets of malignancies might reflect, at least in part, tissuespecific differences in expression or function of a given MYC gene. Since c-Myc and N-myc share substantial functional redundancy, another factor that could influence tumor-specific gene activation would be mechanisms that target aberrations (e.g., translocations) in a given MYC gene in a particular tumor progenitor cell type. We have previously shown that mice deficient for the DNA Ligase4 nonhomologous end joining ͉ pro-B cell lymphoma ͉ genomic instability ͉ immunoglobulin genes T he MYC gene family encodes highly related basic helix-loophelix/leucine zipper transcription factors that function in the control of cell proliferation, apoptosis, and transformation (1, 2). MYC family members include the c-Myc, N-myc, and L-myc proto-oncogenes, all of which have been implicated as oncogenes in particular types of human malignancies (3-5). MYC transcription factors bind to the same DNA target sequences and show a substantial functional redundancy (1, 2, 6), although specific functions are suggested by their different expression patterns (4, 7, 8) . As all 3 MYC family members are abundantly expressed in developing embryos, the late embryonic lethality of knockout mice for individual MYC genes suggests that different Myc proteins might compensate for each other in earlier developmental stages (2). In adults, c-Myc is expressed in most proliferating cells, while N-myc expression becomes restricted to specific differentiated cell types, including developing B and T lineage cells and also cells of the brain, testis, and heart (9-11).
T
he MYC gene family encodes highly related basic helix-loophelix/leucine zipper transcription factors that function in the control of cell proliferation, apoptosis, and transformation (1, 2) . MYC family members include the c-Myc, N-myc, and L-myc proto-oncogenes, all of which have been implicated as oncogenes in particular types of human malignancies (3) (4) (5) . MYC transcription factors bind to the same DNA target sequences and show a substantial functional redundancy (1, 2, 6) , although specific functions are suggested by their different expression patterns (4, 7, 8) . As all 3 MYC family members are abundantly expressed in developing embryos, the late embryonic lethality of knockout mice for individual MYC genes suggests that different Myc proteins might compensate for each other in earlier developmental stages (2) . In adults, c-Myc is expressed in most proliferating cells, while N-myc expression becomes restricted to specific differentiated cell types, including developing B and T lineage cells and also cells of the brain, testis, and heart (9) (10) (11) .
Some studies have indicated that c-Myc, N-myc, and L-myc proteins have differences in their ability to induce apoptosis and to modulate specific target genes. On the other hand, cell culture studies suggested that c-Myc and N-myc possess similar ability to induce cell proliferation and transformation; although c-Myc may be more effective in some contexts (12) (13) (14) . In mice, homozygous replacement of the c-Myc coding exons with the corresponding region of the N-myc gene, N-myc/c-Myc replacement allele (NCR allele), allows normal development, indicating that N-myc can compensate for c-Myc loss when appropriately expressed (15) . Mouse embryonic fibroblasts (MEFs) homozygous for the NCR allele show growth characteristics that are not substantially impaired compared to those of wild-type (WT) MEFs. Similarly, lymphocyte development in NCR mice is normal and purified B and T cells in culture respond to different mitogens only slightly less robustly than WT B and T cells (15) .
Overexpression of specific MYC family genes is frequently associated with particular types of human tumors. N-myc deregulation is almost exclusively associated with solid tumors and only rarely observed in lymphomas. N-myc is amplified in Ϸ30% of cases of neuroblastoma and at lower frequencies in other tumors of neuroectodermal origin (glioma, medulloblastoma, retinoblastoma, small cell lung carcinoma) (3, 4, 16) . Amplification of the L-myc gene is frequently observed in small cell lung carcinomas (3, 5) . The c-Myc gene is commonly translocated in human B cell malignancies and amplified and/or overexpressed in a variety of solid tumors, including breast, ovarian, and gastrointestinal cancers (3, 5) . Translocations of c-Myc in B cell lymphomas typically fuse c-Myc to the Ig heavy chain (IgH) or, less frequently, to the Ig light chain (IgL) loci and are believed to mediate c-Myc overexpression by bringing it into close proximity with strong Ig transcriptional enhancers (17) (18) (19) . In developing B and T lineage cells, the recombination activating gene (RAG)-1 and -2 proteins initiate V(D)J recombination by introducing DNA double-strand breaks (DSBs) at target V, D, and J segments in the Ig and Tcell receptor loci, which are then fused by the nonhomologous DNA end-joining pathway (NHEJ) to make complete V(D)J exons (20) . In the IgH locus of mature B cells, the activation-induced cytidine deaminase (AID) initiates formation of DSBs in large repetitive S region sequences that flank different sets of IgH constant region exons, with the breaks subsequently being joined by NHEJ or alternative end joining to fuse 2 different S regions to effect class switch recombination (CSR) (21) . Oncogenic c-Myc/Ig translocations in B cell lymphomas can be associated with errors in either V(D)J recombination or CSR (17, 18, 22, 23) .
Mice that are deficient for the tumor suppressor p53 and for certain NHEJ factors, such as DNA Ligase 4 (Lig4), invariably develop pro-B cell lymphomas harboring 2 characteristic translocations between chromosome 12 (which contains the IgH locus) and chromosome 15 (which contains the c-Myc locus) (24) (25) (26) (27) (28) (26, 28) .
Even though N-myc amplification is rarely observed in LP pro-B lymphomas, both N-myc and c-Myc are expressed in pro-B cells (9) . In addition, N-myc can support normal B cell development in the 
Results

LP Mice Heterozygous or Homozygous for the NCR Allele Develop
Pro-B Cell Lymphoma. We previously generated the NCR allele by employing gene-targeted mutation to replace the c-Myc coding region (exons 2 and 3) with the corresponding coding region of N-myc (15) . NCR homozygous (N/N) mice are born at subMendelian rate but show relatively normal development and lymphocyte functions (15) . The NCR allele was bred into the LP background, to generate LPMyc N/ϩ and LPMyc N/N mice. As previously observed for LP mice (25) , LPMyc N/ϩ and LPMyc N/N mice were born at reduced frequency and were smaller than WT and heterozygous littermates. LPMyc N/ϩ and LPMyc N/N cohorts were monitored for tumor development. Both LPMyc N/ϩ and LPMyc N/N animals became moribund by 8-12 weeks of age (Fig. 1A) , similar to what we previously reported for LP mice (25, 28) . As also found for LP mice, most of the LPMyc N/ϩ (20/21) and LPMyc N/N (8/9) mice succumbed to B220ϩ/IgMϪ pro-B cell lymphoma (Table 1 and Fig. 1B ) that presented mostly in the peripheral lymph nodes with infiltration of the spleen and thymus, but rarely with involvement of mesenteric lymph nodes. These results demonstrate that replacing c-Myc with N-myc does not alter the kinetics and the spectrum of tumor development in the LP model. lymphomas, we performed Southern blot analysis on DNA extracted from the various tumor samples, using the EcoRI enzyme, which generates a 20-kb fragment encompassing the c-Myc or NCR (referred to as ''Myc'') locus ( Fig. 2A) . Almost all LPMyc N/ϩ tumors analyzed showed significant amplification of the Myc locus (Fig. 2B  Top) , as judged by comparing with normal spleen control DNA. Loading of a similar amount of DNA in each lane was confirmed by reprobing the same membrane with a control probe (Fig. 2B  Bottom) . Most of the amplified Myc fragments did not show rearrangements, indicating that potential translocation breakpoints giving rise to the amplification were located outside of the EcoRI fragment, either upstream or downstream of the c-Myc locus, as previously found in LP tumors (28) .
We analyzed the same panel of lymphomas with a probe hybridizing downstream of the J H region (JH 4-3 ) and found that most samples contained distinct J H rearranged bands, demonstrating clonality of the tumor cell population (Fig. 2B Middle) . The low-level germ-line band detected in some samples likely derives from non-B lineage cells within the tumor. As previously shown for LP tumors (24, 25) , amplification of the J H region is frequent (e.g., tumors 399, 455, 531, and 635) but not invariably detected by this probe. In the latter context, lack of functional NHEJ during V(D)J recombination has been shown to result in extensive deletions in the region of the D-J join extending into the region represented by the J H probe (34) , likely explaining lack of rearranged J H bands in some tumor samples (e.g., tumors 407 and 530).
We next asked whether the NCR allele contributed to the translocations and amplifications in some LPMyc N/ϩ tumors. The targeting strategy used for the N-myc/c-Myc replacement allowed us to distinguish the NCR allele from the WT c-Myc allele by Southern blotting (see Fig. 2 A) . We analyzed DNA from LPMyc N/ϩ tumors by digestion with BamHI enzyme and hybridization with a probe from the 3Ј end of the c-Myc locus, which can recognize both the (Fig. 2D and Table 1 ).
LP/NCR Pro-B Cell Lymphomas Harbor Characteristic Chromosomal
Aberrations. To better characterize the lymphomas arising in LPMyc N/ϩ and LPMyc N/N mice, we obtained metaphase spreads from short-term tumor cell cultures and analyzed them by chromosomal paints and fluorescence in situ hybridization (FISH). As previously shown for pro-B cell lymphomas from NHEJ/p53-deficient mice (28), all analyzed LPMyc N/ϩ samples contained the characteristic complicon with coamplified signals for a 3ЈIgH locus BAC probe and a c-Myc locus BAC probe (Fig. 3 A Left and B) . Sequential reprobing of the same slides with 5ЈIgH and 3ЈIgH BACs ( 5ЈIgH and 3ЈIgH BACs) and 1 or 2 normal ch15's (positive to Myc BAC) were present (Fig. 3A) . Notably, no significant differences in translocation patterns were evident between tumors that amplified the WT c-Myc allele (407, 455, and 399, see Fig. 3 ; and 531 and 654, data not shown) vs. the NCR allele (504, 635, 580, and 591, see Fig. 3 ; and 788, data not shown). Tumor 399 (c-Myc amplified) and 635 (NCR amplified) lacked the t12;15, but still contained the 12;15 complicon. Tumor 635 also harbored another complex 12;15 translocation, not associated with amplification in Ϸ50% of the metaphases (Fig. 3B) . These results indicate that the NCR allele can support the same type of translocations as the unmodified, endogenous c-Myc allele.
Characterization of LPMyc Tumors Lacking Myc Amplification. Some LPMyc N/ϩ and LPMyc N/N tumors lacked amplification of either Myc allele (Fig. 2) . Tumor 871 (LPMyc N/N ) had a rearrangement of the NCR allele not associated with amplification of downstream sequences (Fig. 2D, hybridization with Myc 3Ј probe). Such translocations have been shown in a minor subset of LP and XRCC4/p53 double-deficient pro-B cell tumors (24, 25) . In tumor 871, amplification of a 5Ј Myc probe (MycA) was detected (Fig. 4A) , suggesting that the translocation breakpoint is upstream of the BamHI site downstream of exon 3 (see Fig. 2 A) . Tumor 617 (LPMyc N/ϩ ) showed no significantly amplified bands with 3Ј Myc (Fig. 2B ) and 5Ј Myc (Fig. 4A) probes. Spectral karyotyping (SKY) and FISH showed this tumor to harbor 12;15 translocations and complex translocations involving ch12 and ch16 (Fig. 4B ), but additional analyses suggested ongoing instability/rearrangements, with only a fraction of the metaphases showing c-Myc amplification (not shown), explaining lack of Myc amplification as detected by Southern blot. Tumors 619 and 215 also lacked amplification or rearrangements involving the c-Myc locus (Fig. 2 B and D) , but in these cases SKY analyses also showed the tumors to lack 12;15 translocations. Tumor 619 harbors a clonal 16;4 nonreciprocal translocation (Fig. 4C) ; while tumor 215 has a clonal 17;12 translocation (data not shown) and WT N-myc locus amplification as detected by Southern blotting (Fig. 4A) .
Discussion
Cellular selection for oncogenic activity plays a major role in the appearance of recurrent translocations that activate dominant cellular oncogenes in particular tumors. In this context, overexpression of c-Myc or N-myc in normal cells can generate a p53-dependent oncogenic stress response that promotes cellular apoptosis (2, 35) . Therefore, p53 deficiency confers a strong survival advantage to various cell types exposed to activated c-Myc or N-myc expression, providing a rationale for why translocations/ amplifications of c-Myc or N-myc are so frequently observed in tumors that arise in the context of dual deficiency for NHEJ factors and p53 (24, 28, 33, 36) . Thus, NHEJ deficiency predisposes to increased levels of translocations and p53 deficiency allows tumor progenitor cells to tolerate translocations that activate Myc gene expression. This scenario alone, however, does not explain why certain NHEJ/p53-deficient tumors almost exclusively activate c-Myc and others commonly activate N-myc. In particular, most LP pro-B tumors, and pro-B tumors in mice deficient for p53 plus Xrcc4, Ku70, Ku80, or DNAPKcs (24, 26, 28, 37) , routinely show c-Myc activation via complicons that involve IgH. Yet, selection for c-Myc activation is not specific to pro-B cell tumors, because N-myc is frequently amplified in Artemis/p53-deficient pro-B cell lymphomas (33) . Our current findings establish that the N-myc coding region, when inserted in place of that of c-Myc, indeed substitutes for c-Myc as a target of oncogenic translocations in LP pro-B cell lymphomas. Therefore, we conclude that features of the c-Myc locus may mechanistically contribute to preferential appearance of this locus in complicons of LP mice. Our findings also raise the possibility that mechanistic aspects of the translocation process (e.g., breaks or proximity) might influence tissue and stage specificity of other oncogene translocations in other cell types, developmental stages, or genetic backgrounds.
Several features of a given locus could affect the frequency of translocations and associated amplifications. First, DSBs in both participating chromosomal regions are required. In the case of LP pro-B lymphomas complicons, breaks in the IgH locus are introduced by the RAG endonuclease (28) . However, the mechanism by which DSBs are generated in c-Myc is unknown. While canonical RAG targets were not obvious in the downstream c-Myc regions where the LP pro-B cell lymphoma translocation breakpoints reside, it has been suggested that RAG may generate nicks, and as a result DSBs, in certain general sequence structures (38) . Whatever the origin of the DSBs, sequences and/or transacting factors that could promote the occurrence of and increase the frequency of DSBs around the c-Myc gene relative to N-myc could influence the choice of c-Myc as a preferred translocation partner. Once broken, the 2 translocation target loci must either already lie in close proximity to each other or be brought into proximity to be joined. Therefore, the relative proximity of the broken c-Myc vs. N-myc loci to IgH in LP pro-B cell lymphoma progenitors could be another factor that results in preferential use of c-Myc as a translocation target. Repair pathways active in different cell types, and perhaps the types of ends available to them, might also influence translocation frequency and target sites. In the context of LP pro-B cell lymphomas, a microhomology-based alternative end-joining pathway mediates most translocations (28) . In this regard, the finding that Artemis/p53 double-deficient mice frequently develop pro-B cell lymphomas with N-myc/IgH translocations and complicons might somehow reflect the generation of hairpin IgH targets, although it is also possible that the N-myc region is broken more frequently or lies more proximal to IgH in the Artemis-deficient background.
Materials and Methods
Generation of LPMyc N/؉ and LPMyc N/N Mice. NCR mice were generated previously (15) and crossed into Lig4/p53 germ-line heterozygous mice to obtain triple heterozygous animals. Triple heterozygous and Lig4 heterozygous/p53-null/ Myc N/ϩ or Myc N/N mice were crossed to obtain the experimental cohorts.
FACS Analysis.
Single-cell suspensions from tumor masses and control organs were stained with CyChrome (CyC)-labeled anti-mouse B220 (eBiosciences), FITClabeled anti-mouse CD43 (BD Biosciences), and RPE-labeled anti-mouse IgM (Southern Biotech) antibodies or with CyC-labeled anti-mouse CD3e, FITC-labeled anti-mouse CD8, and RPE-labeled anti-mouse CD4 antibodies (all from BD Biosciences).
Data acquisition was performed on a FACScalibur flow cytometer equipped with CellQuest software (Becton Dickinson). Analysis was performed with FlowJo software (Tree Star).
Southern Blotting. Genomic DNA isolated from tumor masses or normal control tissues was separated on a 0.8% agarose gel and transferred to a Zeta-Probe GT (Bio-Rad) nylon membrane. Hybridization was performed in 50% formamide/ SSCPE at 42°C. The JH 4-3 probe was a 1.6-kb HindIII/EcoEI fragment downstream of JH4; the Myc3Ј probe was a 1.4-kb genomic fragment (XhoI-KpnI) that contains part of exon 3 and the 3Ј-untranslated region of c-Myc; as loading control a probe hybridizing to exon 5 of the MDC1 gene was used.
Metaphase Preparation, SKY, and FISH. Tumor cell suspensions were cultured overnight and colcemid (KaryoMAX Colcemid Solution; GIBCO) was added at the final concentration of 50 ng/ml for 3-5 h. Metaphase spreads were prepared and FISH experiments performed according to standard protocols (39) . Sequential hybridization of slides was performed by dehydration through serial ethanols and reprobing. 
